Enhanced Recovery After Surgery (ERAS) Improves Length of Stay and Decreases Complications After Resection of Abdominal Neuroblastoma
Topic overview
Multi-center study demonstrates ERAS protocol significantly reduces hospital stay from 6.9 to 3.7 days and complications from 96% to 39% in children undergoing abdominal neuroblastoma resection. Protocol achieved earlier diet advancement, reduced opioid use by 61%, and nearly eliminated nasogastric tube dependency.
Key takeaways
- ERAS protocol reduced post-op complications from 96% to 39% in pediatric neuroblastoma resection patients
- Length of stay decreased by 3.2 days (6.9 to 3.7 days) with ERAS implementation across three children's hospitals
- Post-operative opioid use cut by 61% (0.54 to 0.21 MME mg/kg/day) with ERAS pathway
- ERAS patients advanced to regular diet and ambulated 3 days earlier than pre-ERAS cohort
- Nasogastric tube use dropped from 92% to 17% post-operatively with standardized ERAS protocol
Comments